Brief: Lipocine Q3 EPS USD -0.59
06/11/2025 13:00
Nov 06 (Reuters) - Lipocine Q3 basic EPS USD -0.59. Q3 net income USD -3.2 million
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy